| Product Code: ETC9551505 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Circulating Tumor DNA (ctDNA) Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Circulating Tumor DNA (ctDNA) Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Circulating Tumor DNA (ctDNA) Market - Industry Life Cycle |
3.4 Sweden Circulating Tumor DNA (ctDNA) Market - Porter's Five Forces |
3.5 Sweden Circulating Tumor DNA (ctDNA) Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Sweden Circulating Tumor DNA (ctDNA) Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.7 Sweden Circulating Tumor DNA (ctDNA) Market Revenues & Volume Share, By Method, 2021 & 2031F |
3.8 Sweden Circulating Tumor DNA (ctDNA) Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Sweden Circulating Tumor DNA (ctDNA) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Sweden |
4.2.2 Growing awareness about the benefits of ctdna testing for cancer diagnosis and treatment |
4.2.3 Technological advancements in the field of liquid biopsy for cancer detection |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for ctdna testing |
4.3.2 Limited reimbursement policies for ctdna testing in Sweden |
4.3.3 High cost associated with ctdna testing technologies |
5 Sweden Circulating Tumor DNA (ctDNA) Market Trends |
6 Sweden Circulating Tumor DNA (ctDNA) Market, By Types |
6.1 Sweden Circulating Tumor DNA (ctDNA) Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Sweden Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Sweden Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Routine Screening, 2021- 2031F |
6.1.4 Sweden Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Patient Work Up, 2021- 2031F |
6.1.5 Sweden Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Early-Stage Disease, 2021- 2031F |
6.1.6 Sweden Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Late Stage/Metastatic Disease, 2021- 2031F |
6.2 Sweden Circulating Tumor DNA (ctDNA) Market, By Sample |
6.2.1 Overview and Analysis |
6.2.2 Sweden Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Blood, 2021- 2031F |
6.2.3 Sweden Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Urine, 2021- 2031F |
6.2.4 Sweden Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Sweden Circulating Tumor DNA (ctDNA) Market, By Method |
6.3.1 Overview and Analysis |
6.3.2 Sweden Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Sample Preparation, 2021- 2031F |
6.3.3 Sweden Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Ultra-Low Passage Whole Genome Sequencing,, 2021- 2031F |
6.3.4 Sweden Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By ctDNA Quantification, 2021- 2031F |
6.3.5 Sweden Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Copy Number Analysis, 2021- 2031F |
6.3.6 Sweden Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Statistical Analysis, 2021- 2031F |
6.4 Sweden Circulating Tumor DNA (ctDNA) Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Sweden Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Sweden Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Research Laboratories, 2021- 2031F |
6.4.4 Sweden Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Academia, 2021- 2031F |
6.4.5 Sweden Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Research Centers, 2021- 2031F |
7 Sweden Circulating Tumor DNA (ctDNA) Market Import-Export Trade Statistics |
7.1 Sweden Circulating Tumor DNA (ctDNA) Market Export to Major Countries |
7.2 Sweden Circulating Tumor DNA (ctDNA) Market Imports from Major Countries |
8 Sweden Circulating Tumor DNA (ctDNA) Market Key Performance Indicators |
8.1 Adoption rate of ctdna testing in Sweden |
8.2 Number of research studies published on ctdna testing in Sweden |
8.3 Investment in RD for ctdna testing technologies in Sweden |
9 Sweden Circulating Tumor DNA (ctDNA) Market - Opportunity Assessment |
9.1 Sweden Circulating Tumor DNA (ctDNA) Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Sweden Circulating Tumor DNA (ctDNA) Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.3 Sweden Circulating Tumor DNA (ctDNA) Market Opportunity Assessment, By Method, 2021 & 2031F |
9.4 Sweden Circulating Tumor DNA (ctDNA) Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Sweden Circulating Tumor DNA (ctDNA) Market - Competitive Landscape |
10.1 Sweden Circulating Tumor DNA (ctDNA) Market Revenue Share, By Companies, 2024 |
10.2 Sweden Circulating Tumor DNA (ctDNA) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here